Introducing the new AltIndexLearn more
Biomarin Pharmaceutical

Biomarin Pharmaceutical (BMRN) Earnings Prediction

Updated August 11, 2026 · AltIndex alt-data view going into the print

AltIndex AI Score on Biomarin Pharmaceutical is 43 — signals are mixed heading into the print. Underlying trend: 5 tracked signals showing mixed direction over the last 3 months.

Next report
Sunday, October 25, 2026
EPS Estimate
$0.81
AltIndex AI Score
43
AI Prediction
Mixed signals

BMRN stock price — last 3 months

Biomarin Pharmaceutical (BMRN) is trading at $69.55, up 29.9% over the last 3 months (from $53.55 three months ago).

What the alt-data signals say about Biomarin Pharmaceutical right now

Trends across the last 3 months — the run-up to Biomarin Pharmaceutical’s next earnings print.

Signal Current 3-month change
Job postings 229 ↓ -11.2%
LinkedIn headcount 3,218 → +1.6%
Web traffic 103,976 → +0.5%
Employee business outlook 27% Negative ↑ +3pp
Instagram followers 4,219 → +0.0%

Full daily-resolution trend charts on every signal are on the BMRN ticker page.

Get alerted when BMRN signals inflect

AltIndex stock alerts fire when alt-data on BMRN breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.

Sign up to AltIndex →

Biomarin Pharmaceutical earnings: frequently asked questions

When does Biomarin Pharmaceutical report earnings next?
Biomarin Pharmaceutical (BMRN) is scheduled to report next earnings on Sunday, October 25, 2026. The exact pre-market or post-market time is set by the company a few days ahead; see the official investor-relations page for confirmation.
What does the AltIndex AI Score say about Biomarin Pharmaceutical going into earnings?
Current AI Score on Biomarin Pharmaceutical: 43 — Mixed signals. The AI Score combines 10,000+ alternative-data and financial signals into one 0–100 number; higher = signals lean bullish, lower = signals lean bearish. Full per-signal breakdown is on the BMRN ticker page.
What is the EPS estimate for Biomarin Pharmaceutical?
Analyst consensus EPS estimate for Biomarin Pharmaceutical’s next quarter: $0.81. We refresh this from analyst-estimate data daily.
How accurate are AltIndex’s earnings predictions for Biomarin Pharmaceutical?
AltIndex doesn’t predict the exact EPS number — the alt-data signals don’t see the financials. What the signals can do is tell you whether the underlying business momentum (web traffic, hiring, social audience, sentiment) supports the analyst consensus or contradicts it. AltIndex publishes the full pick history at altindex.com/results — including the misses — so you can verify how the signal-driven calls have performed.
Where can I see the full signal breakdown on Biomarin Pharmaceutical?
Visit https://altindex.com/ticker/bmrn for the complete per-signal view: AI Score history, web traffic trend chart, 8-platform social audience tracking, hiring activity, news mention volume, sentiment scoring, insider trades and Congressional disclosures.
How can I get alerted before Biomarin Pharmaceutical reports earnings?
AltIndex stock alerts fire when alt-data signals on a stock break out of their historical range — often days or weeks before the earnings number confirms it. Add BMRN to your watchlist and you’ll get notified when its signals shift. See altindex.com/stock-alerts for the full alert categories.

See every alt-data signal on BMRN

Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Biomarin Pharmaceutical — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.

Sign up to AltIndex → Log in